CoChat

CYP17 mutation E305G causes isolated 17,20 lyase deficiency by selectively altering substrate binding

Open access
Sherbet, Daniel P., Tiosano, Dov, Kwist, Kerri M., Hochberg, Zeev, Auchus, Richard J. · 2003 · Journal of Biological Chemistry

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Abstract

Cytochrome p450c17 (CYP17) converts the C21 steroids pregnenolone and progesterone to the C19 androgen precursors dehydroepiandrosterone (DHEA) and androstenedione, respectively, via sequential 17alpha-hydroxylase and 17,20-lyase reactions. Disabling mutations in CYP17 cause combined 17alpha-hydroxylase/17,20-lyase deficiency, but rare missense mutations cause isolated loss of 17,20-lyase activity by disrupting interactions of redox partner proteins with CYP17. We studied an adolescent male with clinical and biochemical features of isolated 17,20-lyase deficiency, including micropenis, hypospadias, and gynecomastia, who is homozygous for CYP17 mutation E305G, which lies in the active site. When expressed in HEK-293 cells or Saccharomyces cerevisiae, mutation E305G retains 17alpha-hydroxylase activities, converting pregnenolone and progesterone to 17alpha-hydroxysteroids. However, mutation E305G lacks 17,20-lyase activity for the conversion of 17alpha-hydroxypregnenolone to DHEA, which is the dominant pathway to C19 steroids catalyzed by human CYP17 (the delta5-steroid pathway). In contrast, mutation E305G exhibits 11-fold greater catalytic efficiency (kcat/Km) for the cleavage of 17alpha-hydroxyprogesterone to androstenedione compared with wild-type CYP17. We conclude that mutation E305G selectively impairs 17,20-lyase activity for DHEA synthesis despite an increased capacity to form androstenedione. Mutation E305G provides genetic evidence that androstenedione formation from 17alpha-hydroxyprogesterone via the minor delta4-steroid pathway alone is not sufficient for complete formation of the male phenotype in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m307586200

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
FIG. 2 Engineering of yeast strain YiV(B). The yeast homolog ( NCP1 locus) of the gene encoding human CPR was targeted with a human CPR expression cassette adjacent to the yeast ura3 gene, flanked by hisG repeats, inside segments homologous to the 5 ′ - and 3 ′ -ends of the yeast NCP1 locus. Construction of the targeting vector is described under ' Experimental Procedures, ' and key restriction sites are labeled. B/B , BglII end cloned into the BamHI site, destroying this site. Selection on uracil-deficient medium afforded stable recombinants, and plating on medium containing uracil and 5-fluroroorotic acid ( 5FOA ) allowed isolation of clones that had excised the ura3 gene via recombination of the hisG repeats. PCR amplification ( small arrows ) confirmed that integration was correctly targeted as depicted. Chr. , chromosome.
FIG. 2 Engineering of yeast strain YiV(B). The yeast homolog ( NCP1 locus) of the gene encoding human CPR was targeted with a human CPR expression cassette adjacent to the yeast ura3 gene, flanked by hisG repeats, inside segments homologous to the 5 ′ - and 3 ′ -ends of the yeast NCP1 locus. Construction of the targeting vector is described under ' Experimental Procedures, ' and key restriction sites are labeled. B/B , BglII end cloned into the BamHI site, destroying this site. Selection on uracil-deficient medium afforded stable recombinants, and plating on medium containing uracil and 5-fluroroorotic acid ( 5FOA ) allowed isolation of clones that had excised the ura3 gene via recombination of the hisG repeats. PCR amplification ( small arrows ) confirmed that integration was correctly targeted as depicted. Chr. , chromosome.CC-BY · From the PDF
FIG. 3 Steroid metabolism in transfected HEK-293 cells. Medium containing 3 H-labeled steroids was incubated with cells transfected with plasmid pcDNA3 containing no insert (empty vector control ( Vc )), wild-type CYP17 cDNA ( WT ), or CYP17 cDNA containing the E305G mutation; the cells were extracted and chromatographed; and autoradiograms of the chromatography plates are shown. A , transfected cells incubated with [ 3 H]progesterone ( left ) or [ 3 H]17 𝛂 -hydroxyprogesterone ( right ). The migration positions of substrates and metabolites are indicated. Prog , progesterone; AD , androstenedione; 17Prog , 17 𝛂 -hydroxyprogesterone. B , transfected cells incubated with [ 3 H]pregnenolone ( left ) or [ 3 H]17 𝛂 -hydroxypregnenolone ( right ). The migration positions of substrates and metabolites are indicated. Preg , pregnenolone; 17Preg , 17 𝛂 -hydroxypregnenolone.
FIG. 3 Steroid metabolism in transfected HEK-293 cells. Medium containing 3 H-labeled steroids was incubated with cells transfected with plasmid pcDNA3 containing no insert (empty vector control ( Vc )), wild-type CYP17 cDNA ( WT ), or CYP17 cDNA containing the E305G mutation; the cells were extracted and chromatographed; and autoradiograms of the chromatography plates are shown. A , transfected cells incubated with [ 3 H]progesterone ( left ) or [ 3 H]17 𝛂 -hydroxyprogesterone ( right ). The migration positions of substrates and metabolites are indicated. Prog , progesterone; AD , androstenedione; 17Prog , 17 𝛂 -hydroxyprogesterone. B , transfected cells incubated with [ 3 H]pregnenolone ( left ) or [ 3 H]17 𝛂 -hydroxypregnenolone ( right ). The migration positions of substrates and metabolites are indicated. Preg , pregnenolone; 17Preg , 17 𝛂 -hydroxypregnenolone.CC-BY · From the PDF
Image 4
CC-BY · From the PDF
FIG. 4 Activities of yeast microsomes containing CPR and wild-type CYP17 or mutation E305G. Microsomes from yeast strain YiV(B) transformed with expression plasmid V60 containing either wild-type CYP17 cDNA ( WT ; f ) or cDNA for mutation E305G ( ● ) were incubated in the presence of the indicated steroids. Lines were drawn by least-squares fits of the data points ( r ≥ 0.99 in all cases), where each data point represents the mean ± S.D. of three independent experiments (some error bars are unseen because they lie within the data points). A , Lineweaver-Burk plot of microsomes incubated with pregnenolone ( Preg ). B , Lineweaver-Burk plot of microsomes incubated with progesterone ( Prog ). C , autoradiogram of a thin-layer chromatogram of steroids (0.6 𝛍 M) incubated with yeast microsomes in the absence ( -) or presence ( + ) of cytochrome ( Cyt ) b 5 . The migration positions of various steroids are indicated. 17Preg , 17 𝛂 -hydroxypregnenolone; 17Prog , 17 𝛂 -hydroxyprogesterone; AD , androstenedione. The film was intentionally overexposed to reveal traces of products, also accentuating the polar contaminants and/or metabolites that account for ≤ 5% of the total radioactivity, even when inactive microsomes are used (data not shown). D , Lineweaver-Burk plot of data from yeast microsomes incubated in the presence of 17 𝛂 -hydroxyprogesterone. Kinetic constants, extracted from the data in A , B , and D using iterative hyperbolic curve fits (data not shown), are listed in Table III.
FIG. 4 Activities of yeast microsomes containing CPR and wild-type CYP17 or mutation E305G. Microsomes from yeast strain YiV(B) transformed with expression plasmid V60 containing either wild-type CYP17 cDNA ( WT ; f ) or cDNA for mutation E305G ( ● ) were incubated in the presence of the indicated steroids. Lines were drawn by least-squares fits of the data points ( r ≥ 0.99 in all cases), where each data point represents the mean ± S.D. of three independent experiments (some error bars are unseen because they lie within the data points). A , Lineweaver-Burk plot of microsomes incubated with pregnenolone ( Preg ). B , Lineweaver-Burk plot of microsomes incubated with progesterone ( Prog ). C , autoradiogram of a thin-layer chromatogram of steroids (0.6 𝛍 M) incubated with yeast microsomes in the absence ( -) or presence ( + ) of cytochrome ( Cyt ) b 5 . The migration positions of various steroids are indicated. 17Preg , 17 𝛂 -hydroxypregnenolone; 17Prog , 17 𝛂 -hydroxyprogesterone; AD , androstenedione. The film was intentionally overexposed to reveal traces of products, also accentuating the polar contaminants and/or metabolites that account for ≤ 5% of the total radioactivity, even when inactive microsomes are used (data not shown). D , Lineweaver-Burk plot of data from yeast microsomes incubated in the presence of 17 𝛂 -hydroxyprogesterone. Kinetic constants, extracted from the data in A , B , and D using iterative hyperbolic curve fits (data not shown), are listed in Table III.CC-BY · From the PDF
FIG. 5 Lineweaver-Burk plot of [ 3 H]pregnenolone 17 𝛂 -hydroxylation by yeast microsomes containing CYP17 mutation E305G in the presence of 17 𝛂 -hydroxysteroids. Microsomes from yeast strain YiV(B) expressing CYP17 mutation E305G were incubated with [ 3 H]pregnenolone and 2 𝛍 l of ethanol vehicle ( + EtOH ; f ) or with either 40 𝛍 M 17 𝛂 -hydroxypregnenolone ( 17Preg ; ● ) or 20 𝛍 M 17 𝛂 -hydroxyprogesterone ( 17Prog ; Œ ) both added in 2 𝛍 l of ethanol. Lines were drawn by least-squares fits of the data points ( r ≥ 0.99 in all cases), where each data point represents the mean ± S.D. of three independent experiments (some error bars are unseen because they lie within the data points). Lines intersect at the y intercepts , allowing calculation of KI (app) values for competitive inhibition (Table III). The inset shows the type I difference spectrum obtained when a suspension of yeast expressing mutation E305G was incubated with 10 𝛍 M 17 𝛂 -hydroxyprogesterone. Error bar , 0.02 absorbance units.
FIG. 5 Lineweaver-Burk plot of [ 3 H]pregnenolone 17 𝛂 -hydroxylation by yeast microsomes containing CYP17 mutation E305G in the presence of 17 𝛂 -hydroxysteroids. Microsomes from yeast strain YiV(B) expressing CYP17 mutation E305G were incubated with [ 3 H]pregnenolone and 2 𝛍 l of ethanol vehicle ( + EtOH ; f ) or with either 40 𝛍 M 17 𝛂 -hydroxypregnenolone ( 17Preg ; ● ) or 20 𝛍 M 17 𝛂 -hydroxyprogesterone ( 17Prog ; Œ ) both added in 2 𝛍 l of ethanol. Lines were drawn by least-squares fits of the data points ( r ≥ 0.99 in all cases), where each data point represents the mean ± S.D. of three independent experiments (some error bars are unseen because they lie within the data points). Lines intersect at the y intercepts , allowing calculation of KI (app) values for competitive inhibition (Table III). The inset shows the type I difference spectrum obtained when a suspension of yeast expressing mutation E305G was incubated with 10 𝛍 M 17 𝛂 -hydroxyprogesterone. Error bar , 0.02 absorbance units.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 7

  1. Lin, 1993, Endocrinology, 132, 2498, 10.1210/endo.132.6.8504753 · doi:10.1210/endo.132.6.8504753 · Paper page
  2. Youngblood, 1992, Mol. Endocrinol., 6, 927
  3. Biglieri, 1966, J. Clin. Investig., 15, 1945
  4. Miura, 1996, J. Clin. Endocrinol. Metab., 81, 3797
  5. Auchus, 1999, Mol. Endocrinol., 13, 1169
  6. Costa-Santos, 2003, J. Clin. Endocrinol. Metab.
  7. Lee-Robichaud, 1999, Biochem. J., 342, 309, 10.1042/bj3420309 · doi:10.1042/bj3420309 · Paper page

Cited by

See all 131

Metadata

Authors
Sherbet, D. P., Tiosano, D., Kwist, K. M., Hochberg, Z., & Auchus, R. J.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Rambam Health Care Campus (IL)
  • Meyer Children's Hospital (IL)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2003-12
Volume
278
Issue
49
Pages
48563-48569
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2079050871
Cited by
131
References
47
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 2 · 2019: 6 · 2018: 8 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 10 · 2013: 10 · 2012: 4
FWCI
1.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r03dk056641-03, 5k08dk002387-06)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R03-DK-56641, K08 DK 02387)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
Keywords
CYP17, 17,20-lyase deficiency, P450c17, 17α-hydroxylase, substrate binding, androstenedione, 17-hydroxyprogesterone, male phenotype, congenital adrenal hyperplasia, micropenis, hypospadias, gynecomastia
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, Cell Line, Humans, Molecular Sequence Data, Steroid 17-alpha-Hydroxylase, Substrate Specificity, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, DNA Primers, Mutation, Missense

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.